177 related articles for article (PubMed ID: 19156217)
1. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer.
Becker M; Korn C; Sienerth AR; Voswinckel R; Luetkenhaus K; Ceteci F; Rapp UR
PLoS One; 2009; 4(1):e4230. PubMed ID: 19156217
[TBL] [Abstract][Full Text] [Related]
2. Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.
Chiba T; Seki A; Aoki R; Ichikawa H; Negishi M; Miyagi S; Oguro H; Saraya A; Kamiya A; Nakauchi H; Yokosuka O; Iwama A
Hepatology; 2010 Sep; 52(3):1111-23. PubMed ID: 20648475
[TBL] [Abstract][Full Text] [Related]
3. E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.
Chagraoui J; Niessen SL; Lessard J; Girard S; Coulombe P; Sauvageau M; Meloche S; Sauvageau G
Genes Dev; 2006 Aug; 20(15):2110-20. PubMed ID: 16882984
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF.
Kranc KR; Bamforth SD; Bragança J; Norbury C; van Lohuizen M; Bhattacharya S
Mol Cell Biol; 2003 Nov; 23(21):7658-66. PubMed ID: 14560011
[TBL] [Abstract][Full Text] [Related]
5. Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.
Michael LE; Westerman BA; Ermilov AN; Wang A; Ferris J; Liu J; Blom M; Ellison DW; van Lohuizen M; Dlugosz AA
Neoplasia; 2008 Dec; 10(12):1343-9, 5p following 1349. PubMed ID: 19048113
[TBL] [Abstract][Full Text] [Related]
6. Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.
Xu CR; Lee S; Ho C; Bommi P; Huang SA; Cheung ST; Dimri GP; Chen X
Mol Cancer Res; 2009 Dec; 7(12):1937-45. PubMed ID: 19934271
[TBL] [Abstract][Full Text] [Related]
7. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.
Bruggeman SW; Valk-Lingbeek ME; van der Stoop PP; Jacobs JJ; Kieboom K; Tanger E; Hulsman D; Leung C; Arsenijevic Y; Marino S; van Lohuizen M
Genes Dev; 2005 Jun; 19(12):1438-43. PubMed ID: 15964995
[TBL] [Abstract][Full Text] [Related]
8. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.
Bruggeman SW; Hulsman D; Tanger E; Buckle T; Blom M; Zevenhoven J; van Tellingen O; van Lohuizen M
Cancer Cell; 2007 Oct; 12(4):328-41. PubMed ID: 17936558
[TBL] [Abstract][Full Text] [Related]
9. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
[TBL] [Abstract][Full Text] [Related]
10. Bmi1, stem cells, and senescence regulation.
Park IK; Morrison SJ; Clarke MF
J Clin Invest; 2004 Jan; 113(2):175-9. PubMed ID: 14722607
[TBL] [Abstract][Full Text] [Related]
11. Conditional activation of Bmi1 expression regulates self-renewal, apoptosis, and differentiation of neural stem/progenitor cells in vitro and in vivo.
Yadirgi G; Leinster V; Acquati S; Bhagat H; Shakhova O; Marino S
Stem Cells; 2011 Apr; 29(4):700-12. PubMed ID: 21305672
[TBL] [Abstract][Full Text] [Related]
12. GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors.
Westerman BA; Blom M; Tanger E; van der Valk M; Song JY; van Santen M; Gadiot J; Cornelissen-Steijger P; Zevenhoven J; Prosser HM; Uren A; Aronica E; van Lohuizen M
PLoS One; 2012; 7(5):e35943. PubMed ID: 22574128
[TBL] [Abstract][Full Text] [Related]
13. Polycomb (PcG) proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation.
Kim HG; Kim DJ; Li S; Lee KY; Li X; Bode AM; Dong Z
J Biol Chem; 2012 Sep; 287(38):31920-8. PubMed ID: 22843710
[TBL] [Abstract][Full Text] [Related]
14. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.
Fan C; He L; Kapoor A; Gillis A; Rybak AP; Cutz JC; Tang D
Biochim Biophys Acta; 2008 Nov; 1782(11):642-8. PubMed ID: 18817867
[TBL] [Abstract][Full Text] [Related]
15. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
16. Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.
Dovey JS; Zacharek SJ; Kim CF; Lees JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11857-62. PubMed ID: 18697930
[TBL] [Abstract][Full Text] [Related]
17. Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes.
Oguro H; Yuan J; Tanaka S; Miyagi S; Mochizuki-Kashio M; Ichikawa H; Yamazaki S; Koseki H; Nakauchi H; Iwama A
J Exp Med; 2012 Mar; 209(3):445-54. PubMed ID: 22351929
[TBL] [Abstract][Full Text] [Related]
18. BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.
Zhang XW; Sheng YP; Li Q; Qin W; Lu YW; Cheng YF; Liu BY; Zhang FC; Li J; Dimri GP; Guo WJ
Mol Cancer; 2010 Feb; 9():40. PubMed ID: 20170541
[TBL] [Abstract][Full Text] [Related]
19. Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression.
Mao L; Ding J; Perdue A; Yang L; Zha Y; Ren M; Huang S; Cui H; Ding HF
Oncogene; 2012 Aug; 31(33):3785-95. PubMed ID: 22120721
[TBL] [Abstract][Full Text] [Related]
20. Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.
Liu Y; Liu F; Yu H; Zhao X; Sashida G; Deblasio A; Harr M; She QB; Chen Z; Lin HK; Di Giandomenico S; Elf SE; Yang Y; Miyata Y; Huang G; Menendez S; Mellinghoff IK; Rosen N; Pandolfi PP; Hedvat CV; Nimer SD
Sci Signal; 2012 Oct; 5(247):ra77. PubMed ID: 23092893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
